Results 241 to 250 of about 397,641 (267)

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

AI-Enabled Sensor Technologies for Remote Arrhythmic Monitoring in High-Risk Cardiomyopathy Genotypes. [PDF]

Sensors (Basel)
Tetaj N, Segreti A, Piccirillo F, Ferro A, Ligorio V, Spagnolo A, Pelullo M, Crispino SP, Grigioni F.   +8 more
europepmc   +1 more source

Progress of metabolomics‐centric multi‐omics research in medicine

iMetaOmics, EarlyView.
The graphical abstract illustrates a holistic roadmap for metabolomics‐centric multi‐omics integration in medical research. The upper panel depicts the technological transition from traditional bulk analysis to high‐resolution single‐cell and spatial methodologies, specifically addressing inherent challenges such as molecular complexity and dynamic ...
Ziyi Wang, Shiwen Deng, Xiaoxu Wang, Xiao Chang, Na Guo, Peng Chen, Hongjun Yang   +6 more
wiley   +1 more source

Sepsis-induced cardiomyopathy: mechanisms, epidemiology, diagnosis, and treatments. [PDF]

Front Immunol
Cao F, Yan T, Liang C, Liu A, Wang J.
europepmc   +1 more source

Stressed out with Sepsis. [PDF]

, 2019
Baram, Michael, Hilton, Robert
core   +1 more source

The Role and Therapeutic Potential of Voltage‐Gated Potassium Channel Kv1.3 in Metabolism‐Related Disorders

iNew Medicine, EarlyView.
ABSTRACT Over the past three decades, the global burden of common metabolic diseases such as obesity, diabetes, and atherosclerosis has steadily increased, becoming a serious public health issue that poses a major threat to human health worldwide. Potassium channels, particularly the voltage‐gated Kv1.3 subtype, serve as critical regulators of cellular
Wenjun Zhen, Junda Liu, Xixi Chen, Shi Chen, Yuanyuan Tian, Baoming Wu, Fengxia Yan   +6 more
wiley   +1 more source

Autoantibody Profiling in Cardiomyopathies: Toward Immune-Guided Risk Stratification and Therapy. [PDF]

J Clin Med
Marmai A, Civieri G, Iop L, Martini M, Vadori M, Cozzi E, Tona F.   +6 more
europepmc   +1 more source

Genetic evaluation of early-onset atrial fibrillation: impact on patient management. [PDF]

Eur Heart J
Laws JL, Shabani M, Williams HL, Grauherr DD, Kilbourne WM, Crawford DM, Ogunmola I, Sun L, Virk Z, Cathey B, El-Harasis MA, Pelphrey CJ, Quintana JA, Murphy BS, Davogustto GE, Ponder ME, Irani OM, Daw JM, Varghese BT, Saavedra P, Abraham RL, Estrada JC, Murray KT, Clair WK, Shen ST, Kanagasundram AN, Montgomery JA, Ellis CR, Fish F, Richardson TD, Crossley GH, Hung RR, Dendy JM, Wright A, Wells QS, Ye F, Tandri H, Stevenson WG, Lancaster M, Kannankeril PJ, Stevenson LW, Roden DM, Yoneda ZT, Shoemaker MB.   +43 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Artur Oreziak, Roberto Barriales Villa, Theodore P Abraham   +2 more
exaly